“Female issue” in cardiology
Aim. To study the effects of hormonal replacement therapy (HRT) with a combined medication (1 mg 17В-estradiol and 2 mg drospirenone; Angeliq) among women in early post-menopause. Material and methods. In total, 30 postmenopausal patients with climacteric syndrome were examined and prescribed HRT. T...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2010-08-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/2107 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Aim. To study the effects of hormonal replacement therapy (HRT) with a combined medication (1 mg 17В-estradiol and 2 mg drospirenone; Angeliq) among women in early post-menopause. Material and methods. In total, 30 postmenopausal patients with climacteric syndrome were examined and prescribed HRT. The following parameters were studied: blood pressure (BP) level, vegetative disorder severity, visceral obesity, metabolic status after 6 months of Angeliq therapy, microcirculation (MC) and carotid artery intima-media thickness (IMT) after 1 year of Angeliq therapy. Results. After 6 months of the treatment, BP level was reduced, metabolic status improved, and vegetative disorders were less severe. After 1 year, MC parameters improved, and carotid IMT levels were reduced. Conclusion. Angeliq demonstrated vegeto-corrective and antihypertensive effects, together with improvement in metabolic status, visceral obesity, MC, and carotid IMT parameters among female patients in early postmenopause. |
|---|---|
| ISSN: | 1728-8800 2619-0125 |